Patents Assigned to Canadian Blood Service
  • Method for preventing and inhibiting human HLA alloimmune response to platelet transfusion
    Patent number: 6749852
    Abstract: The present invention relates to a method for preventing HLA alloimmune response to platelet transfusion. The method comprises the step of presensitizing platelets with at least one monoclonal HLA antibody. The platelets if administered to a patient prevent an HLA alloimmune response from said patient.
    Type: Grant
    Filed: November 10, 2000
    Date of Patent: June 15, 2004
    Assignee: Canadian Blood Services
    Inventors: Alan H. Lazarus, John Freedman, Andrew R. Crow
  • Method of producing human IFN-&agr; using sendai virus-infected hematopoietic stem cells
    Patent number: 6472208
    Abstract: The present invention relates to a novel method for producing human natural interferon-&agr; using ex vivo expanded cord blood hematopoietic cells infected with sendaivirus, on a large scale.
    Type: Grant
    Filed: July 7, 2000
    Date of Patent: October 29, 2002
    Assignees: Héma-Québec, Canadian Blood Services
    Inventors: Réal Lemieux, Sonia Néron, Chantal Proulx